Governor's Institute
Governor's Institute
S3 E1: Let's Talk About Buprenorphine with a Physician
S3 E1: Let's Talk About Buprenorphine with a Physician
S3 E1: Let's Talk About Buprenorphine with a Physician
Wednesday 13th September 2023
Join Dr. Blake Fagan on the Addiction Medicine Podcast as he explains new buprenorphine guidelines and their impact on opioid use disorder treatment.
24 minutes
Compassionate
Informative
Empowering
Supportive
Non-judgmental
About this podcast
Author:
Governor's Institute
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Intimate Relationships
Sobriety Toolkit
Family Recovery from Addiction
Body & Mind
Links:
Visit site
Episodes:
20 (View all)
Do you want to link to this podcast?
Get the buttons here!Buprenorphine Breakthrough: Dr. Blake Fagan Explains New Guidelines
Episode Overview
- Insights into the new regulations for prescribing buprenorphine
- Understanding the safety and long-term use of buprenorphine
- Considerations for different age groups and concurrent substance use
- Best practices for patient-centered care in treating opioid use disorder
So it's actually built to be safe. And the FDA, or sorry, the federal government just wanted everyone to get some additional training once. It's only a one-time requirement. So when you sign up this next time for your DEA and you have your eight hours and you check that box, you won't have to do that again in the future.
When it comes to understanding the latest in opioid use disorder treatment, this episode of the Addiction Medicine Podcast is a must-listen. Kicking off Season 3, the show dives into the evolving landscape of buprenorphine prescription requirements. Dr. Blake Fagan, Clinical Director of Substance Use Disorder Initiatives at the Mountain Area Health Education Center (MAHEC) in Asheville, NC, brings his expertise to the table, shedding light on these significant changes. Dr.
Fagan discusses the new regulations and what they mean for both practitioners and patients. He breaks down complex topics like the safety of buprenorphine, its long-term use, and how it can be tailored to different age groups. The conversation also touches on concurrent substance use and the best practices for providing patient-centered care. Through relatable analogies and a compassionate approach, Dr. Fagan dispels common misconceptions about buprenorphine treatment.
This episode is particularly valuable for healthcare professionals navigating these new guidelines, but it's also accessible for anyone interested in addiction medicine. The insights shared by Dr. Fagan are not only informative but also grounded in real-world experience, making the discussion both engaging and practical. Whether you're a seasoned practitioner or new to the field, you'll find this episode offers a wealth of knowledge to enhance your understanding of buprenorphine's role in treating opioid use disorder.